Ardelyx presents additional data on educational needs related to IBS-C

Ardelyx announced that data detailing educational needs related to irritable bowel syndrome with constipation, IBS-C, across healthcare disciplines was presented via a poster at the 2024 American Association of Nurse Practitioners, AANP, Annual Conference, currently taking place in Nashville, Tennessee. Poster IND, entitled “Educational Needs Related to Irritable Bowel Syndrome with Constipation Management Across Disciplines: a Comparison of Nurse Practitioners, Physician Assistants, and Physicians” includes findings from a case-based survey involving 410 cross-disciplinary healthcare professionals and sheds light on practice differences and educational requirements related to the diagnosis and management of IBS-C. The data reveals notable differences between nurse practitioners/physician assistants and physicians, particularly in their choice of IBS-C diagnostic criteria and testing methodologies, tendency to refer patients to specialists and approach to assessing pain levels. It also shows that gastroenterology HCPs are more likely to prescribe linaclotide, plecanatide or tenapanor for IBS-C patients who avoid social events due to discomfort, whereas primary care physicians are more likely to prescribe neuromodulators.